Disclosure Quest - Search SEC Filings

Name	Type of Offering	Accepted Date
RespireRx Pharmaceuticals Inc. See All Filings	1-A/A	2021-12-01 16:05:42 UTC
Amount To Be Raised $7,500,000 Associated Brokers / Dealers Primary Capital LLC CIK Number 0000849636 Filed Document 0001493152-21-030189 Accepted Date 2021-12-01 16:05:42 UTC Type of Offering 1-A/A Industry PHARMACEUTICAL PREPARATIONS Offering Tier Tier2 Principal Place of Business NEW JERSEY Revenue or Assets $0 State of Jurisdiction DELAWARE Type of Security Equity (common or preferred stock)
RespireRx Pharmaceuticals Inc. See All Filings	1-A/A	2021-10-12 17:20:32 UTC
Amount To Be Raised $7,500,000 Associated Brokers / Dealers Primary Capital LLC CIK Number 0000849636 Filed Document 0001493152-21-025228 Accepted Date 2021-10-12 17:20:32 UTC Type of Offering 1-A/A Industry PHARMACEUTICAL PREPARATIONS Offering Tier Tier2 Principal Place of Business NEW JERSEY Revenue or Assets $0 State of Jurisdiction DELAWARE Type of Security Equity (common or preferred stock)
RespireRx Pharmaceuticals Inc. See All Filings	1-A	2021-08-09 09:15:41 UTC
Amount To Be Raised $7,500,000 Associated Brokers / Dealers Primary Capital LLC CIK Number 0000849636 Filed Document 0001493152-21-018997 Accepted Date 2021-08-09 09:15:41 UTC Type of Offering 1-A Industry PHARMACEUTICAL PREPARATIONS Offering Tier Tier2 Principal Place of Business NEW JERSEY Revenue or Assets $0 State of Jurisdiction DELAWARE Type of Security Equity (common or preferred stock)
RespireRx Pharmaceuticals Inc. See All Filings	D	2020-08-12 13:13:38 UTC
Amount To Be Raised $193,250 Associated Brokers / Dealers N/A CIK Number 0000849636 Filed Document 0000849636-20-000002 Exclusions or Exemptions 506b Accepted Date 2020-08-12 13:13:38 UTC Type of Offering D Industry Biotechnology Principal Place of Business NEW JERSEY Revenue or Assets Decline to Disclose Type of Security Debt
RespireRx Pharmaceuticals Inc. See All Filings	D	2020-08-12 12:30:00 UTC
Amount To Be Raised $2,000,000 Associated Brokers / Dealers N/A CIK Number 0000849636 Filed Document 0000849636-20-000001 Exclusions or Exemptions 506b Accepted Date 2020-08-12 12:30:00 UTC Type of Offering D Industry Biotechnology Principal Place of Business NEW JERSEY Revenue or Assets Decline to Disclose Type of Security Equity
RespireRx Pharmaceuticals Inc. See All Filings	D	2018-09-24 14:15:18 UTC
Amount To Be Raised $1,500,000 Associated Brokers / Dealers N/A CIK Number 0000849636 Filed Document 0000849636-18-000001 Exclusions or Exemptions 506b Accepted Date 2018-09-24 14:15:18 UTC Type of Offering D Industry Biotechnology Principal Place of Business NEW JERSEY Revenue or Assets Decline to Disclose Type of Security Equity
RespireRx Pharmaceuticals Inc. See All Filings	D	2017-09-13 11:30:35 UTC
Amount To Be Raised $1,150,000 Associated Brokers / Dealers N/A CIK Number 0000849636 Filed Document 0000849636-17-000004 Exclusions or Exemptions 506b Accepted Date 2017-09-13 11:30:35 UTC Type of Offering D Industry Biotechnology Principal Place of Business NEW JERSEY Revenue or Assets Decline to Disclose Type of Security Equity
RespireRx Pharmaceuticals Inc. See All Filings	D	2017-03-23 15:15:57 UTC
Amount To Be Raised $1,500,000 Associated Brokers / Dealers N/A CIK Number 0000849636 Filed Document 0000849636-17-000002 Exclusions or Exemptions 506b Accepted Date 2017-03-23 15:15:57 UTC Type of Offering D Industry Biotechnology Principal Place of Business NEW JERSEY Revenue or Assets Decline to Disclose Type of Security Equity
RespireRx Pharmaceuticals Inc. See All Filings	D	2017-01-13 14:09:04 UTC
Amount To Be Raised $3,000,000 Associated Brokers / Dealers N/A CIK Number 0000849636 Filed Document 0000849636-17-000001 Exclusions or Exemptions 506b Accepted Date 2017-01-13 14:09:04 UTC Type of Offering D Industry Biotechnology Principal Place of Business NEW JERSEY Revenue or Assets Decline to Disclose Type of Security Equity
RespireRx Pharmaceuticals Inc. See All Filings	D	2016-01-20 00:00:00 UTC
Amount To Be Raised $2,500,000 Associated Brokers / Dealers N/A CIK Number 0000849636 Filed Document 0000849636-16-000002 Exclusions or Exemptions 506b Accepted Date 2016-01-20 00:00:00 UTC Type of Offering D Industry Biotechnology Principal Place of Business NEW JERSEY Revenue or Assets Decline to Disclose Type of Security Equity
CORTEX PHARMACEUTICALS INC/DE/ See All Filings	D	2015-09-11 00:00:00 UTC
Amount To Be Raised $3,000,000 Associated Brokers / Dealers Gelband & Co., Inc. and Aurora Capital LLC CIK Number 0000849636 Filed Document 0001560208-15-000002 Exclusions or Exemptions 506b Accepted Date 2015-09-11 00:00:00 UTC Type of Offering D Industry Biotechnology Principal Place of Business NEW JERSEY Revenue or Assets Decline to Disclose Type of Security Equity
CORTEX PHARMACEUTICALS INC/DE/ See All Filings	D	2014-11-17 00:00:00 UTC
Amount To Be Raised $1,000,000 Associated Brokers / Dealers Gelband & Co., Inc. and Aurora Capital LLC CIK Number 0000849636 Filed Document 0000849636-14-000004 Exclusions or Exemptions 506b Accepted Date 2014-11-17 00:00:00 UTC Type of Offering D Industry Biotechnology Principal Place of Business NEW JERSEY Revenue or Assets Decline to Disclose Type of Security Equity
CORTEX PHARMACEUTICALS INC/DE/ See All Filings	D	2014-04-01 00:00:00 UTC
Amount To Be Raised $1,500,000 Associated Brokers / Dealers Gelband & Co., Inc., Mahoney, Kenneth R., Kelkar, Sachin R., and H.C. Wainright & Co., LLC CIK Number 0000849636 Filed Document 0000849636-14-000002 Exclusions or Exemptions 506b Accepted Date 2014-04-01 00:00:00 UTC Type of Offering D Industry Biotechnology Principal Place of Business NEW JERSEY Revenue or Assets Decline to Disclose Type of Security Equity